This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting to approve September 2026 financial results
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Midcap 150 and 1.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on 6 November 2026 to approve the company's unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The filing does not provide any financial figures or performance guidance.
Shareholders may see stock volatility around the results release. The earnings impact cannot be assessed because no figures or outlook are provided.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2,829 Cr | ₹1,197 Cr | +136.3% |
| Operating profit | ₹394.8 Cr | ₹153.0 Cr | +158.1% |
| Profit after tax | ₹322.4 Cr | ₹121.3 Cr | +165.7% |
| EBITDA margin | 22.8% | 20.8% | +1.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.